This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, E.
Right arrow Articles by Pelicci, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, E.
Right arrow Articles by Pelicci, P. G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2005, p. 8874-8886, Vol. 25, No. 20
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.20.8874-8886.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Nucleophosmin Is Required for DNA Integrity and p19Arf Protein Stability{dagger}

Emanuela Colombo,1 Paola Bonetti,1 Eros Lazzerini Denchi,1,2,{ddagger} Paola Martinelli,1 Raffaella Zamponi,1 Jean-Christophe Marine,3 Kristian Helin,1 Brunangelo Falini,4 and Pier Giuseppe Pelicci1,2,5*

Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy,1 IFOM Institute, Via Adamello 16, 20139 Milan, Italy,2 Laboratory for Molecular Cancer Biology, Flanders Interuniversity Institute for Biotechnology, University of Ghent, B-9052 Ghent, Belgium,3 Institute of Hematology and Internal Medicine, University of Perugia, 06100 Perugia, Italy,4 Department of Medicine, Surgery and Dentistry, University of Milan, Milan, Italy5

Received 24 June 2005/ Returned for modification 2 July 2005/ Accepted 21 July 2005

Nucleophosmin (NPM) is a nucleolar phosphoprotein that binds the tumor suppressors p53 and p19Arf and is thought to be indispensable for ribogenesis, cell proliferation, and survival after DNA damage. The NPM gene is the most frequent target of genetic alterations in leukemias and lymphomas, though its role in tumorigenesis is unknown. We report here the first characterization of a mouse NPM knockout strain. Lack of NPM expression results in accumulation of DNA damage, activation of p53, widespread apoptosis, and mid-stage embryonic lethality. Fibroblasts explanted from null embryos fail to grow and rapidly acquire a senescent phenotype. Transfer of the NPM mutation into a p53-null background rescued apoptosis in vivo and fibroblast proliferation in vitro. Cells null for both p53 and NPM grow faster than control cells and are more susceptible to transformation by activated oncogenes, such as mutated Ras or overexpressed Myc. In the absence of NPM, Arf protein is excluded from nucleoli and is markedly less stable. Our data demonstrate that NPM regulates DNA integrity and, through Arf, inhibits cell proliferation and are consistent with a putative tumor-suppressive function of NPM.


* Corresponding author. Mailing address: European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Phone: 39-02-57489838. Fax: 39-02-57489851. E-mail: piergiuseppe.pelicci{at}ifom-ieo-campus.it.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

{ddagger} Present address: The Rockefeller University, 1230 York Avenue, New York, N.Y.


Molecular and Cellular Biology, October 2005, p. 8874-8886, Vol. 25, No. 20
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.20.8874-8886.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Romesser, P. B., Perlman, D. H., Faller, D. V., Costello, C. E., McComb, M. E., Denis, G. V. (2009). Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma. Am. J. Pathol. 175: 25-35 [Abstract] [Full Text]  
  • Freeman-Anderson, N. E., Zheng, Y., McCalla-Martin, A. C., Treanor, L. M., Zhao, Y. D., Garfin, P. M., He, T.-C., Mary, M. N., Thornton, J. D., Anderson, C., Gibbons, M., Saab, R., Baumer, S. H., Cunningham, J. M., Skapek, S. X. (2009). Expression of the Arf tumor suppressor gene is controlled by Tgf{beta}2 during development. Development 136: 2081-2089 [Abstract] [Full Text]  
  • Dhar, S. K., St. Clair, D. K. (2009). Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis. J. Biol. Chem. 284: 16409-16418 [Abstract] [Full Text]  
  • Cullen, S. P., Afonina, I. S., Donadini, R., Luthi, A. U., Medema, J. P., Bird, P. I., Martin, S. J. (2009). Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing. J. Biol. Chem. 284: 5137-5147 [Abstract] [Full Text]  
  • Li, Z., Boone, D., Hann, S. R. (2008). Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc. Natl. Acad. Sci. USA 105: 18794-18799 [Abstract] [Full Text]  
  • Maggi, L. B. Jr., Kuchenruether, M., Dadey, D. Y. A., Schwope, R. M., Grisendi, S., Townsend, R. R., Pandolfi, P. P., Weber, J. D. (2008). Nucleophosmin Serves as a Rate-Limiting Nuclear Export Chaperone for the Mammalian Ribosome. Mol. Cell. Biol. 28: 7050-7065 [Abstract] [Full Text]  
  • Di Fiore, P. P. (2008). Playing both sides: nucleophosmin between tumor suppression and oncogenesis. JCB 182: 7-9 [Abstract] [Full Text]  
  • Bonetti, P., Davoli, T., Sironi, C., Amati, B., Pelicci, P. G., Colombo, E. (2008). Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7{gamma}. JCB 182: 19-26 [Abstract] [Full Text]  
  • Mascaux, C., Bex, F., Martin, B., Burny, A., Haller, A., Paesmans, M., Willard-Gallo, K., Ninane, V., Sculier, J-P. (2008). The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma. Eur Respir J 32: 678-686 [Abstract] [Full Text]  
  • Zimmerman, R. S., Rosenberg, N. (2008). Changes in p19Arf Localization Accompany Apoptotic Crisis during Pre-B-Cell Transformation by Abelson Murine Leukemia Virus. J. Virol. 82: 8383-8391 [Abstract] [Full Text]  
  • Yogev, O., Saadon, K., Anzi, S., Inoue, K., Shaulian, E. (2008). DNA Damage-Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway. Cancer Res. 68: 1398-1406 [Abstract] [Full Text]  
  • Zou, Y., Wu, J., Giannone, R. J., Boucher, L., Du, H., Huang, Y., Johnson, D. K., Liu, Y., Wang, Y. (2008). Nucleophosmin/B23 Negatively Regulates GCN5-dependent Histone Acetylation and Transactivation. J. Biol. Chem. 283: 5728-5737 [Abstract] [Full Text]  
  • Boehrer, S., Ades, L., Braun, T., Galluzzi, L., Grosjean, J., Fabre, C., Le Roux, G., Gardin, C., Martin, A., de Botton, S., Fenaux, P., Kroemer, G. (2008). Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 111: 2170-2180 [Abstract] [Full Text]  
  • Okada, M., Jang, S.-W., Ye, K. (2007). Ebp1 Association with Nucleophosmin/B23 Is Essential for Regulating Cell Proliferation and Suppressing Apoptosis. J. Biol. Chem. 282: 36744-36754 [Abstract] [Full Text]  
  • Li, J., Sejas, D. P., Burma, S., Chen, D. J., Pang, Q. (2007). Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis 28: 1163-1170 [Abstract] [Full Text]  
  • Falini, B., Nicoletti, I., Bolli, N., Martelli, M. P., Liso, A., Gorello, P., Mandelli, F., Mecucci, C., Martelli, M. F. (2007). Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. haematol 92: 519-532 [Abstract] [Full Text]  
  • Pelletier, C. L., Maggi, L. B. Jr., Brady, S. N., Scheidenhelm, D. K., Gutmann, D. H., Weber, J. D. (2007). TSC1 Sets the Rate of Ribosome Export and Protein Synthesis through Nucleophosmin Translation. Cancer Res. 67: 1609-1617 [Abstract] [Full Text]  
  • Falini, B., Nicoletti, I., Martelli, M. F., Mecucci, C. (2007). Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 109: 874-885 [Abstract] [Full Text]  
  • Tompkins, V. S., Hagen, J., Frazier, A. A., Lushnikova, T., Fitzgerald, M. P., di Tommaso, A., Ladeveze, V., Domann, F. E., Eischen, C. M., Quelle, D. E. (2007). A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability. J. Biol. Chem. 282: 1322-1333 [Abstract] [Full Text]  
  • Testa, U., Riccioni, R. (2007). Deregulation of apoptosis in acute myeloid leukemia. haematol 92: 81-94 [Abstract] [Full Text]  
  • Beekman, C., Nichane, M., De Clercq, S., Maetens, M., Floss, T., Wurst, W., Bellefroid, E., Marine, J.-C. (2006). Evolutionarily Conserved Role of Nucleostemin: Controlling Proliferation of Stem/Progenitor Cells during Early Vertebrate Development. Mol. Cell. Biol. 26: 9291-9301 [Abstract] [Full Text]  
  • Falini, B., Martelli, M. P., Bolli, N., Bonasso, R., Ghia, E., Pallotta, M. T., Diverio, D., Nicoletti, I., Pacini, R., Tabarrini, A., Galletti, B. V., Mannucci, R., Roti, G., Rosati, R., Specchia, G., Liso, A., Tiacci, E., Alcalay, M., Luzi, L., Volorio, S., Bernard, L., Guarini, A., Amadori, S., Mandelli, F., Pane, F., Lo-Coco, F., Saglio, G., Pelicci, P.-G., Martelli, M. F., Mecucci, C., for the GIMEMA Acute Leukemia Working Party, (2006). Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood 108: 1999-2005 [Abstract] [Full Text]  
  • Enomoto, T., Lindstrom, M. S., Jin, A., Ke, H., Zhang, Y. (2006). Essential Role of the B23/NPM Core Domain in Regulating ARF Binding and B23 Stability. J. Biol. Chem. 281: 18463-18472 [Abstract] [Full Text]  
  • Li, J., Sejas, D. P., Rani, R., Koretsky, T., Bagby, G. C., Pang, Q. (2006). Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem/Progenitor Cells. J. Biol. Chem. 281: 16536-16545 [Abstract] [Full Text]  
  • Yu, Y., Maggi, L. B. Jr., Brady, S. N., Apicelli, A. J., Dai, M.-S., Lu, H., Weber, J. D. (2006). Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear Export. Mol. Cell. Biol. 26: 3798-3809 [Abstract] [Full Text]  
  • Colombo, E., Martinelli, P., Zamponi, R., Shing, D. C., Bonetti, P., Luzi, L., Volorio, S., Bernard, L., Pruneri, G., Alcalay, M., Pelicci, P. G. (2006). Delocalization and Destabilization of the Arf Tumor Suppressor by the Leukemia-Associated NPM Mutant.. Cancer Res. 66: 3044-3050 [Abstract] [Full Text]